안과용 진단기기 시장 : 시장 규모, 점유율 및 성장률, 산업 분석 - 유형별, 용도별, 지역별 인사이트 및 예측(2025-2034년)

Growth Factors of ophthalmic diagnostic devices Market

The global ophthalmic diagnostic devices market was valued at USD 2.72 billion in 2025 and is projected to grow to USD 2.89 billion in 2026, eventually reaching USD 4.82 billion by 2034, reflecting a CAGR of 6.60% during the forecast period. North America dominated the market in 2025 with a 38.20% share, driven by the high number of ophthalmic procedures, technological adoption, and new product launches. Key players in the market include Carl Zeiss Meditech AG, Topcon Corporation, NIDEK CO., LTD., Alcon Inc., EssilorLuxottica, Canon Medical Systems Corporation, Bausch + Lomb, Ziemer Ophthalmic Systems AG, Haag-Streit Group, and Visionix. These companies are focusing on technological innovations, strategic partnerships, and global expansions to strengthen their market presence.

Ophthalmic diagnostic devices include optical coherence tomography (OCT), aberrometer & topography systems, fundus cameras, ophthalmic ultrasound, slit lamps, ophthalmoscopes, and tonometers. These instruments are used for detecting, diagnosing, and monitoring ocular diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration, cataracts, refractive errors, and other vision impairments. The market growth is primarily driven by increasing prevalence of eye disorders, technological advancements, and the expanding geriatric population.

Impact of COVID-19

The COVID-19 pandemic temporarily disrupted the ophthalmic diagnostic devices market, as patient visits and elective procedures were postponed, and healthcare resources were redirected toward pandemic management. In March 2020, the American Academy of Ophthalmology advised U.S. ophthalmologists to halt non-urgent care, significantly reducing patient visits. Supply chain disruptions further impacted the market. However, as restrictions eased, patient volumes recovered, elective procedures resumed, and the market witnessed steady growth from 2021 onwards, driven by increasing awareness of eye health and a rising prevalence of ocular diseases.

Market Drivers

Rising Prevalence of Eye Disorders: According to the World Health Organization (2023), around 2.2 billion people worldwide suffer from vision impairment. Factors such as aging populations, diabetes, and unhealthy lifestyles are increasing the incidence of eye diseases. This trend drives demand for diagnostic procedures and advanced ophthalmic devices.

Technological Advancements: The integration of Artificial Intelligence (AI) in diagnostic devices improves the accuracy and efficiency of detecting ocular conditions. AI applications, like retinal image analysis for diabetic retinopathy, help reduce ophthalmologists' workload and increase screening coverage. Teleophthalmology and portable devices are expanding accessibility, especially in remote locations.

Growing Geriatric Population: The rising number of elderly individuals susceptible to eye disorders has significantly contributed to the demand for ophthalmic diagnostic devices.

Market Restraints

Shortage of Skilled Professionals: A limited number of trained ophthalmic technicians is restraining market growth. In the U.S., there are fewer than 60,000 ophthalmic technicians supporting over 19,000 ophthalmologists (2024 AAO report). This imbalance limits effective deployment of advanced devices.

High Cost and Regulatory Challenges: Advanced devices such as OCT scanners and fundus cameras are expensive. Regulatory approvals from authorities like the U.S. FDA and European Medicines Agency (EMA) involve complex procedures, which can delay market entry.

Market Trends

AI Integration and Digitalization: AI-driven diagnostics, teleophthalmology, and portable devices are transforming eye care. Innovations such as IDx-DR and Google's ARDA system facilitate efficient point-of-care diagnostics.

Product Launches and Strategic Collaborations: Companies are expanding product portfolios through partnerships, acquisitions, and technological upgrades. For example, in November 2023, Canon Medical Systems collaborated with Cleveland Clinic to improve imaging and IT technologies for ophthalmic diagnostics.

Segmentation Analysis

By Product Type:

• Optical Coherence Tomography (OCT): Largest share with 30.80% in 2026, driven by technological advancements and increasing adoption of portable devices.
• Fundus Cameras: Expected to witness significant growth due to reimbursement policies and rising awareness.
• Other Devices: Slit lamps, tonometers, and perimeters show steady growth, supported by rising ophthalmic clinics worldwide.

By End-User:

• Hospitals: Largest share (46.37% in 2026) due to higher diagnostic volumes and advanced instrument availability.
• Ophthalmic Clinics: Rapid growth expected from specialty clinics and expansion of services.
• Other Settings: Telehealth and academic clinics are projected to grow as strategic initiatives improve access to eye care.

Regional Insights

• North America: Market size USD 1.04 billion in 2025, projected USD 1.10 billion in 2026. Growth driven by high procedural volumes and technological adoption in the U.S.
• Europe: Second-largest, with UK USD 0.13 billion and Germany USD 0.23 billion in 2026, supported by healthcare infrastructure and increasing diagnostic demand.
• Asia Pacific: Fastest-growing; Japan USD 0.18 billion, China USD 0.16 billion, India USD 0.12 billion in 2026, fueled by rising surgeries and awareness.
• Latin America & Middle East & Africa: Moderate growth, supported by aging populations and rising awareness of ocular disorders.

Competitive Landscape

Key players include Carl Zeiss Meditech AG, Topcon Corporation, Alcon Inc., NIDEK CO., LTD., EssilorLuxottica, Canon Medical Systems, Bausch + Lomb, Ziemer Ophthalmic Systems, Haag-Streit Group, and Visionix. Strategies focus on product launches, global partnerships, and technological innovation. Recent developments include Bausch + Lomb's SeeNa system launch in 2024, Topcon Korea Medical expansion, and Visionix partnerships in Europe and North America.

Conclusion

The ophthalmic diagnostic devices market is projected to grow from USD 2.72 billion in 2025 to USD 4.82 billion by 2034, driven by technological innovation, AI integration, rising prevalence of eye disorders, and aging populations. Hospitals dominate the end-user segment, while OCT leads product type adoption. North America holds the largest market share, and Asia Pacific demonstrates the fastest growth. Strategic collaborations, innovative product launches, and digital solutions are expected to sustain market expansion, improving access to high-quality eye care globally.

Segmentation By Product Type, End-user, and Region

Segmentation By Product Type

• Optical Coherence Tomography
• Aberrometer & Topography Systems
• Fundus Camera
• Ophthalmic Ultrasound
• Other Devices

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America (By Product Type, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, End-user, and Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of Regulatory Scenario
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.4. Impact of COVID-19 on the Market

5. Global Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights, and Forecast - By Product Type
  • 5.1.1. Optical Coherence Tomography
  • 5.1.2. Aberrometer & Topography Systems
  • 5.1.3. Fundus Camera
  • 5.1.4. Ophthalmic Ultrasound
  • 5.1.5. Other Devices
• 5.2. Market Analysis, Insights, and Forecast - By End-user
  • 5.2.1. Hospitals
  • 5.2.2. Ophthalmic Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights, and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights, and Forecast - By Product Type
  • 6.1.1. Optical Coherence Tomography
  • 6.1.2. Aberrometer & Topography Systems
  • 6.1.3. Fundus Camera
  • 6.1.4. Ophthalmic Ultrasound
  • 6.1.5. Other Devices
• 6.2. Market Analysis, Insights, and Forecast - By End-user
  • 6.2.1. Hospitals
  • 6.2.2. Ophthalmic Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights, and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights, and Forecast - By Product Type
  • 7.1.1. Optical Coherence Tomography
  • 7.1.2. Aberrometer & Topography Systems
  • 7.1.3. Fundus Camera
  • 7.1.4. Ophthalmic Ultrasound
  • 7.1.5. Other Devices
• 7.2. Market Analysis, Insights, and Forecast - By End-user
  • 7.2.1. Hospitals
  • 7.2.2. Ophthalmic Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights, and Forecast - By Country/ Sub-Region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Spain
  • 7.3.5. Italy
  • 7.3.6. Scandinavia
  • 7.3.7. Rest of Europe

8. Asia Pacific Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights, and Forecast - By Product Type
  • 8.1.1. Optical Coherence Tomography
  • 8.1.2. Aberrometer & Topography Systems
  • 8.1.3. Fundus Camera
  • 8.1.4. Ophthalmic Ultrasound
  • 8.1.5. Other Devices
• 8.2. Market Analysis, Insights, and Forecast - By End-user
  • 8.2.1. Hospitals
  • 8.2.2. Ophthalmic Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights, and Forecast - By Country/ Sub-Region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Southeast Asia
  • 8.3.6. Rest of Asia Pacific

9. Latin America Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights, and Forecast - By Product Type
  • 9.1.1. Optical Coherence Tomography
  • 9.1.2. Aberrometer & Topography Systems
  • 9.1.3. Fundus Camera
  • 9.1.4. Ophthalmic Ultrasound
  • 9.1.5. Other Devices
• 9.2. Market Analysis, Insights, and Forecast - By End-user
  • 9.2.1. Hospitals
  • 9.2.2. Ophthalmic Clinics
  • 9.2.3. Others
• 9.3. Market Analysis, Insights, and Forecast - By Country/ Sub-Region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America

10. Middle East and Africa Ophthalmic Diagnostic Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights, and Forecast - By Product Type
  • 10.1.1. Optical Coherence Tomography
  • 10.1.2. Aberrometer & Topography Systems
  • 10.1.3. Fundus Camera
  • 10.1.4. Ophthalmic Ultrasound
  • 10.1.5. Other Devices
• 10.2. Market Analysis, Insights, and Forecast - By End-user
  • 10.2.1. Hospitals
  • 10.2.2. Ophthalmic Clinics
  • 10.2.3. Others
• 10.3. Market Analysis, Insights, and Forecast - By Country/ Sub-Region
  • 10.3.1. GCC
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global and Regional Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Product Types, SWOT analysis, Recent developments, strategies, financials (based on availability))
  • 11.2.1. Carl Zeiss Meditech AG
  • 11.2.2. Alcon Inc.
  • 11.2.3. CANON MEDICAL SYSTEMS CORPORATION (Canon Inc.)
  • 11.2.4. EssilorLuxottica
  • 11.2.5. Bausch + Lomb
  • 11.2.6. NIDEK CO., LTD.
  • 11.2.7. Topcon Corporation
  • 11.2.8. Ziemer Ophthalmic Systems AG
  • 11.2.9. Haag-Streit Group
  • 11.2.10. Visionix